ETHEMA HEALTH Corp
Healthcare · Services-General Medical & Surgical Hospitals, NEC · CO · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | |
|---|---|---|---|---|---|---|
| Revenue | $6.0M | $5.3M | $4.8M | $1.9M | $338,996 | $359,947 |
| Operating income | −$1.3M | −$541,920 | $489,117 | $2,105 | −$163,344 | −$4.2M |
| Net income | −$2.2M | $1.0M | $295,188 | −$1.5M | $3.1M | −$15.0M |
| Total assets | $12.2M | $11.5M | $6.6M | $6.6M | $3.8M | $3.2M |
| Total liabilities | $19.6M | $17.7M | $15.4M | $16.0M | $18.4M | $23.2M |
| Equity | −$7.5M | −$6.2M | −$9.2M | −$10.7M | −$15.7M | −$20.0M |
| EPS (diluted) | $0.00 | $0.00 | — | — | — | — |
| Shares out. | 3.73B | 3.73B | 3.73B | 2.27B | 1.84B | 155.5M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2024- Operating margin
- −22.2%
- Net margin
- −36.0%
- Return on equity
- 29.0%
- Return on assets
- −17.8%
- Return on capital (ROCE)
- −53.2%
- Liabilities / assets
- 161.3%
- Debt / equity
- —
- Book value / share
- $-0.00
- Revenue growth (YoY)
- 12.6%
- Net income growth (YoY)
- −315.2%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2024- Altman Z″ (distress)
- -17.97distress
- Accruals / assets
- −14.1%clean
- Piotroski F-Score
- 4/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 3 severe● 4 warning● 3 good- Negative shareholder equity
- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- High leverage (liabilities > 70% of assets)
- Negative operating cash flow
- Strong return on equity (>15%)
- Revenue is growing year-over-year
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗May 15, 2026
- NT 10-Kmissed a reporting deadline ↗Apr 13, 2026
- NT 10-Kmissed a reporting deadline ↗Mar 30, 2026
- NT 10-Qmissed a reporting deadline ↗Nov 14, 2025
- NT 10-Qmissed a reporting deadline ↗May 15, 2025
- NT 10-Kmissed a reporting deadline ↗Mar 31, 2025
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Greene Eileen Maria | Jun 18, 2024 | Buy | 5.0M | $0.00 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Material events
SEC Form 8-K · most recent- Entered a material agreement · Completed an acquisition or disposition · New financial obligationJan 23, 2025
- Shareholder voteJan 10, 2025
- Entered a material agreementOct 29, 2024
- Entered a material agreement · Unregistered equity saleJul 12, 2024
- Completed an acquisition or disposition · New financial obligationJun 18, 2024
- Entered a material agreementFeb 7, 2024
- Entered a material agreement · Completed an acquisition or disposition · New financial obligation · Unregistered equity sale · Regulation FD disclosureAug 11, 2023
- Changed auditorJul 18, 2023
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.